Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Foie » Néoplasie

18. Novembre 2024

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 3501


	Articles 1 - 20 / 70001

	Investigating the diagnostic and prognostic significance of genes related to fatty acid metabolism in hepatocellular carcinoma. BMC Gastroenterol Zhao SS, Bai RR, Zhang BH, Sun XR, Huang N, Chen Y, Sun ZJ, Sun LM, Zhang Y, Cui ZQ. PMID: 39548390 [PubMed - indexed for MEDLINE]
	Role and therapeutic potential of E3s in the tumor microenvironment of hepatocellular carcinoma. Front Immunol Wang H, Li Q, Tang Q, Shi G, Wu G, Mao X, Wu C, Zhang L, Liu J, Li J, Li B. PMID: 39544935 [PubMed - indexed for MEDLINE]
	Hepatobiliary-Phase Hypointense Nodules Without Arterial-Phase Hyperenhancement: Developing a Risk Stratification for Hypervascular Transformation Based on a Real-World Observational Cohort Study. Technol Cancer Res Treat Li N, Wang Y, Yang L, Yang C, Zeng M. PMID: 39544080 [PubMed - indexed for MEDLINE]
	Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies. Mol Cancer Zhu C, Liao JY, Liu YY, Chen ZY, Chang RZ, Chen XP, Zhang BX, Liang JN. PMID: 39543660 [PubMed - indexed for MEDLINE]
	Nomogram for predicting early recurrence of hepatocellular carcinoma with narrow resection margin. Sci Rep Zhang J, Wang Z, Wu Q, Zeng J, Liu J, Zeng J. PMID: 39543345 [PubMed - indexed for MEDLINE]
	Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma. Cancer Immunol Immunother Cao YZ, Pan JY, Zheng GL, An C, Zuo MX. PMID: 39540963 [PubMed - indexed for MEDLINE]
	A Novel Prognostic Nomogram Based on TIGIT and NKG2A Can Predict Relapse-Free Survival of Hepatocellular Carcinoma After Hepatectomy. Cancer Med Wang J, Cao Y, Tian Y, Dai C, Jin T, Xu F. PMID: 39540362 [PubMed - indexed for MEDLINE]
	The Extent of Tumor in the Peritoneum and Liver Influences Outcomes After Surgery for Synchronous Liver and Peritoneal Colorectal Metastases: A Cohort Study. J Gastrointest Cancer Salas PS, Urdzik J, Graf W, Isaksson B, Birgisson H. PMID: 39537942 [PubMed - indexed for MEDLINE]
	Extracellular vesicles in hepatocellular carcinoma: unraveling immunological mechanisms for enhanced diagnosis and overcoming drug resistance. Front Immunol Su L, Yue Y, Yan Y, Sun J, Meng L, Lu J, Zhang L, Liu J, Chi H, Liu S, Yang Z, Tang X. PMID: 39530097 [PubMed - indexed for MEDLINE]
	Risk factors for wound complications after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) compared to repeated liver resection - a propensity score matching analysis. Langenbecks Arch Surg Khajeh E, Sabetkish N, Ramouz A, Werba A, Klotz R, Michalski CW, Mehrabi A, Pianka F. PMID: 39535576 [PubMed - indexed for MEDLINE]
	DSA-Former: A Network of Hybrid Variable Structures for Liver and Liver Tumour Segmentation. Int J Med Robot Qin J, Luo H, He F, Qin G. PMID: 39535347 [PubMed - indexed for MEDLINE]
	Causal relationship between gout and liver cancer: A Mendelian randomization and transcriptome analysis. Medicine (Baltimore) Xi J, Cheng X, Liu J. PMID: 39533594 [PubMed - indexed for MEDLINE]
	Prognostic importance of the Scottish inflammatory prognostic score in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study. BMC Cancer Shen S, Qiu X, Yang C, Li J, Peng Y, Wen Z, Luo H, Xiang B. PMID: 39533231 [PubMed - indexed for MEDLINE]
	Comparison of drug-eluting bead transarterial chemoembolization combined with apatinib versus drug-eluting bead transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: a randomized, prospective, multicenter phase III trial. Signal Transduct Target Ther Duan X, Li H, Kuang D, Chen P, Zhang M, Li T, Jiao D, Li Y, He X, Xing C, Wang H, Liu Y, Xie L, Zhang S, Zhang Q, Zhu P, Chang Y, Xie J, Ren J, Han X. PMID: 39532849 [PubMed - indexed for MEDLINE]
	Maintenance immunosuppressive therapy in liver transplantation: results from CESIT study, an Italian retrospective cohort study. BMJ Open Bellini A, Finocchietti M, Rosa AC, Masiero L, Trapani S, Cardillo M, Massari M, Spila Alegiani S, Pierobon S, Ferroni E, Zanforlini M, Leoni O, Ledda S, Garau D, Davoli M, Addis A, Belleudi V, CESIT Study Group. PMID: 39532354 [PubMed - indexed for MEDLINE]
	CT/MRI LI-RADS 2024 Update: Treatment Response Assessment. Radiology Aslam A, Chernyak V, Miller FH, Bashir M, Do R, Sirlin C, Lewandowski RJ, Kim CY, Kielar AZ, Kambadakone AR, Yarmohammadi H, Kim E, Owen D, Charalel RA, Shenoy-Bhangle A, Burke LM, Mendiratta-Lala M. PMID: 39530896 [PubMed - indexed for MEDLINE]
	Head-to-head study of [(18)F]FAPI-04 PET/CT and [(18)F]FDG PET/CT for non-invasive assessment of liver cancer and its immunohistochemical markers. BMC Cancer Liang Z, Peng H, Li W, Liu Z. PMID: 39528951 [PubMed - indexed for MEDLINE]
	Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation. Cancer Immunol Immunother Lu X, Zhu Q, Cai J, Yang Z, Gu G, Pang L, Su M, Zhang F, Lin H, Wu W, Xu L, Liu C. PMID: 39527136 [PubMed - indexed for MEDLINE]
	Outcomes of Pediatric Hepatocellular Carcinoma: A Single-Center Experience With Resection Versus Transplantation. Pediatr Transplant Medio P, Matesanz S, Margareto M, Ostos P, Palomo C, Hernández Oliveros F, Moreno AA. PMID: 39523995 [PubMed - indexed for MEDLINE]
	Phytochemicals and Their Nanoformulations for Targeting Hepatocellular Carcinoma: Exploring Potential and Targeting Strategies. Cell Biochem Funct Rab SO, Roopashree R, Altalbawy FMA, Kumar MR, Chahar M, Singh M, Kubaev A, Alamir HTA, Mohammed F, Kadhim AJ, Alhadrawi M. PMID: 39521962 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 70001

Page 1 de 3501



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité